LIVZON PHARMACEUTICAL GROUP INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.89 CNY | +0.45% |
|
+2.92% | +13.94% |
| Jun. 06 | Chinese drugmakers developing generic drugs of Novo Nordisk's Ozempic | RE |
| Jun. 06 | Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China | RE |
Quotes 5-day view
End-of-day quote Shenzhen S.E.| 2024-05-31 | 2024-06-03 | 2024-06-04 | 2024-06-05 | 2024-06-06 | |
|---|---|---|---|---|---|
| Last | 38.7 ¥ | 38.85 ¥ | 39.81 ¥ | 39.71 ¥ | 39.89 ¥ |
| Volume | 4 271 262 | 4 695 924 | 5 832 439 | 4 166 330 | 3 957 319 |
| Change | -0.15% | +0.39% | +2.47% | -0.25% | +0.45% |
| Opening | 38.85 | 38.70 | 39.05 | 39.75 | 39.62 |
| High | 39.05 | 39.26 | 39.93 | 40.20 | 40.35 |
| Low | 38.41 | 38.42 | 38.85 | 39.63 | 39.62 |
Performance
| 1 day | +0.45% | ||
| 1 week | +2.92% | ||
| Current month | +3.07% | ||
| 1 month | -1.51% | ||
| 3 months | +0.61% | ||
| 6 months | +16.64% | ||
| Current year | +13.94% | ||
| 1 year | +4.42% | ||
| 3 years | -17.79% | ||
| 5 years | +79.44% | ||
| 10 years | +132.04% |
Volumes
marketsDaily volume
3 957 319
Avg. Volume 20 sessions
4 972 592
Avg. Volume 20 sessions CNY
198 356 694.88
Avg. Volume 20 sessions USD
27 392 861.21
Record volume 1
82 177 415
Record volume 2
73 655 378
Record volume 3
63 480 948
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (CNY)
32 354 724 183
Capitalization (USD)
4 468 155 055
Net sales (CNY)
12 430 038 330
Net sales (USD)
1 716 575 863
Number of employees
8 933
Sales / Employee (CNY)
1 391 474
Sales / Employee (USD)
192 161
Free-Float
38.45 %
Free-Float capitalization (CNY)
12 537 533 067
Free-Float capitalization (USD)
1 731 420 779
Average Daily Capital Traded
0.61%
Highs and lows
1 week
38.42
40.35
1 month
38.0541.47
Current year
32.7041.47
1 year
31.7241.47
3 years
28.8852.36
5 years
22.2162.20
10 years
15.9062.20
Indicators
Moving average 5 days
39.39
Moving average 20 days
39.37
Moving average 50 days
38.59
Moving average 100 days
37.68
Price spread / (MMA5)
-1.25%
Price spread / (MMA20)
-1.30%
Price spread / (MMA50)
-3.26%
Price spread / (MMA100)
-5.54%
STIM
RSI 9 days
62.28
RSI 14 days
58.47
Sector Comparison - Other Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +0.45% | +2.92% | +13.94% | +4.42% | 4.47B | ||
| +0.66% | +2.73% | +43.64% | +88.97% | 754B | ||
| +0.25% | +5.77% | +40.50% | +79.63% | 630B | ||
| +0.31% | +0.78% | -6.58% | -7.43% | 352B | ||
| +0.83% | +4.81% | +19.72% | +18.64% | 331B | ||
| +1.89% | +7.84% | +8.78% | +24.47% | 298B | ||
| -0.49% | +2.95% | +18.40% | +6.77% | 250B | ||
| +0.15% | +2.32% | +12.32% | +6.51% | 217B | ||
| +1.95% | +5.41% | -0.41% | -15.41% | 216B | ||
| -0.55% | +1.56% | +6.13% | +38.18% | 164B | ||
| -2.54% | +2.13% | +0.03% | -24.94% | 163B | ||
| -0.91% | +0.47% | +0.47% | -5.02% | 124B | ||
| -1.65% | -8.21% | +11.81% | +17.82% | 85.51B | ||
| -0.87% | +1.57% | -20.33% | -37.57% | 82.87B | ||
| -0.06% | -0.37% | -21.19% | -16.22% | 79.55B | ||
| +0.97% | +4.50% | +50.54% | +22.18% | 70.73B | ||
| Average | +0.19% | +3.01% | +11.11% | +12.56% | ||
| Weighted average by Cap. | +0.18% | +3.75% | +19.56% | +33.53% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | +13.94% | ||
| 2023 | +7.79% | ||
| 2022 | -19.22% | ||
| 2021 | -0.72% | ||
| 2020 | +20.18% | ||
| 2019 | +74.19% | ||
| 2018 | -50.80% | ||
| 2017 | +45.18% | ||
| 2016 | +3.60% | ||
| 2015 | +51.01% | ||
| 2014 | +27.78% | ||
| 2013 | +11.18% | ||
| 2012 | +70.09% | ||
| 2011 | -53.31% | ||
| 2010 | +10.68% | ||
| 2009 | +127.79% | ||
| 2008 | -59.39% | ||
| 2007 | +609.78% | ||
| 2006 | +44.51% | ||
| 2005 | -35.89% | ||
| 2004 | +7.19% | ||
| 2003 | -24.35% | ||
| 2002 | -5.86% | ||
| 2001 | -27.79% | ||
| 2000 | +107.84% | ||
| 1999 | -4.73% | ||
| 1998 | -0.30% | ||
| 1997 | -9.58% | ||
| 1996 | +159.77% | ||
| 1995 | -9.84% |
- Stock Market
- Equities
- 000513 Stock
- Quotes Livzon Pharmaceutical Group Inc.
